Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination ; volume:6 ; number:1 ; day:4 ; month:6 ; year:2018 ; pages:1-17 ; date:12.2018
Journal for ImmunoTherapy of Cancer ; 6, Heft 1 (4.6.2018), 1-17, 12.2018
- Urheber
-
Gong, Jun
- Beteiligte Personen und Organisationen
-
Le, Thang Q.
Massarelli, Erminia
Hendifar, Andrew E.
Tuli, Richard
SpringerLink (Online service)
- DOI
-
10.1186/s40425-018-0361-7
- URN
-
urn:nbn:de:101:1-2018081021311548091430
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gong, Jun
- Le, Thang Q.
- Massarelli, Erminia
- Hendifar, Andrew E.
- Tuli, Richard
- SpringerLink (Online service)
Ähnliche Objekte (12)
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Manipulation of PD‐L1 Endosomal Trafficking Promotes Anticancer Immunity
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Regulatory mechanisms of PD-1/PD-L1 in cancers
PD-1/PD-L1 binding studies using microscale thermophoresis
The PD-1:PD-L1 axis in Inflammatory Arthritis
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Manipulation of PD‐L1 Endosomal Trafficking Promotes Anticancer Immunity
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Regulatory mechanisms of PD-1/PD-L1 in cancers
PD-1/PD-L1 binding studies using microscale thermophoresis
The PD-1:PD-L1 axis in Inflammatory Arthritis
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
PD-L1 Expression als Prognosemarker beim Endometriumkarzinom
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Manipulation of PD‐L1 Endosomal Trafficking Promotes Anticancer Immunity
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Regulatory mechanisms of PD-1/PD-L1 in cancers
PD-1/PD-L1 binding studies using microscale thermophoresis
The PD-1:PD-L1 axis in Inflammatory Arthritis
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Expression von PD-L1 und PD-1 im kleinzelligen Lungenkarzinom
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors